Two recent decisions of the Federal Court, AstraZeneca AB v Pharmacor Pty Ltd [2026] FCA 88 and Janssen Pharmaceutica NV v Juno Pharmaceuticals Pty Ltd [2025] FCA 1538 suggest the tide may be turning back to originators seeking preliminary injunctions (PIs) to restrain generic market entry. Previously, PIs were routinely granted to pharmaceutical patentees …
>> Read more
Australia’s life sciences ecosystem is experiencing sustained growth, driven by advances in biotechnology, digital health, precision medicine, agricultural innovation and materials science. While pharmaceuticals continue to dominate in terms of patent filings and regulatory complexity, the broader life sciences sector – encompassing agtech, medtech and next-generation materials such as semiconductors and battery technologies – is …
>> Read more
It is with great sadness that we advise that former Principal of POF, David Tadgell, passed away a few days ago. David joined Phillips Ormonde Fitzpatrick in 1983 and became a partner in 1993. David was a key member of the Chemistry & Life Sciences group at POF and served on our management committee and …
>> Read more
This year, Phillips Ormonde Fitzpatrick (POF) proudly marks our 30th anniversary in the Sydney office. This milestone provides an opportunity to reflect on POF’s growth and to recognise where we are today. “Our Sydney office opened in Chatswood in 1994 following ever-increasing demand from our Sydney and NSW-based clients. We are very pleased that our …
>> Read more
Congratulations to our Managing Principal, Ross McFarlane, for being named as one IAM’s Global Leaders for 2023. This is a very significant achievement as being awarded this status as Global Leader requires attorneys to already be ranked in IAM Patent’s Gold Tier. Ross has also been a highly recommended individual in the IAM Patent 1000 …
>> Read more
The factual situation in Campaigntrack v Real Estate Tool Box is not an uncommon one. Wanting a better software program for its operations, a business enters into an arrangement with a software developer who has experience in that area to develop a new program with reference to a competitor program’s functionality. What was interesting and …
>> Read more
The Federal Court recently deliberated on a patent infringement and validity dispute between Global Tech Corporation Pty Ltd (Global Tech) and Reflex Instruments Asia Pacific Pty Ltd (Reflex). In arriving at its decision that infringement had occurred, the Court had to consider what technical field the patent belonged to, and then weigh up arguments around …
>> Read more
Venkat Thandra; Ahmed Farouk Shaaban [2022] APO 65 is yet another manner of manufacture decision in relation to computer related inventions by IP Australia. You can probably guess the outcome, but of note is the approach taken to Hearings at IP Australia where they emanate from an Examiner Objection as well as the time to …
>> Read more
While Australia does have a form of patent linkage, it is currently a limited system and in practice is not very useful for patentees. There is no patent listing system (equivalent to the US FDA’s Orange Book) in Australia. The current patent linkage system extends only to the requirements asked of companies when they apply …
>> Read more
The Full Court has unanimously dismissed the appeal in State of Escape Accessories v Schwartz, rejecting the claims against Stefanie Schwartz and Chuchka Pty Ltd for copyright infringement in respect of State of Escape’s well-known perforated neoprene tote bag (the Escape Bag) on the basis that it was not a “work of artistic craftsmanship” under …
>> Read more
